Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Pro Medicus Limited ( (AU:PME) ) is now available.
Pro Medicus director Anthony Barry Hall has increased his direct holding in the company through an on-market purchase of 8,146 ordinary shares at $122.00 per share. Following the transaction, Hall’s total interest rose to 24,174,166 shares, spread across his personal holding, the Akay Superannuation Fund, the Anthony Hall Family Trust, and the Anthony Hall Testamentary Trust.
The move modestly lifts insider ownership in Pro Medicus, underscoring Hall’s continued financial commitment to the company. The acquisition may be viewed by investors as a vote of confidence in the company’s prospects, although no changes were reported in any related contracts or derivative interests.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$128.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is an Australian-listed company in the healthcare technology sector, specialising in medical imaging IT solutions. Its primary business involves providing software and related services to radiology and healthcare providers, with its shares traded on the ASX under ordinary fully paid share capital.
Average Trading Volume: 324,048
Technical Sentiment Signal: Hold
Current Market Cap: A$11.3B
For an in-depth examination of PME stock, go to TipRanks’ Overview page.